Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Ongoing pharmaceutical reforms in France

2 references·14 citing·38 second hop

FromToDepth

this work references cited by second hop

References

2009Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance150 cited
2013Estonia: Health System Review.119 cited

Cited by

2009Soft regulations in pharmaceutical policy making97 cited
2012Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications97 cited
2010Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?93 cited
2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review92 cited
2012International Variability in the Reimbursement of Cancer Drugs by Publically Funded Drug Programs89 cited
2013Demand-side policies to encourage the use of generic medicines: an overview87 cited
2013Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries86 cited
2011Does the Market Share of Generic Medicines Influence the Price Level?85 cited
2015The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians79 cited
2011European countries with small populations can obtain low prices for drugs: Lithuania as a case history78 cited
2012SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMS

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

75 cited

2014Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders73 cited

2010Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications69 cited

2013Generic Medicines: Solutions for a Sustainable Drug Market?67 cited